Market potential Target ophthalmic centers performing cataract surgery and intraoperative procedures where the HOLOS IntraOp Wavefront Aberrometer can optimize IOL selection and surgical outcomes, highlighting upsell opportunities for real-time guidance tools.

Innovation edge Position Clarity Medical Systems as a niche disruptor with continuous real-time intraoperative aberrometry, offering value propositions around precision improvements, patient satisfaction, and differentiation for surgeons adopting advanced cataract care.

Strategic partnerships Explore collaborations with ophthalmology device distributors, surgical centers, and hospital systems to expand adoption, leveraging Natus Medical ownership history to gauge integration and cross-selling potential for complementary devices or services.

Expansion signals Capitalize on product enhancements like the HOLOS Barrett Intraocular Lens Formula and ongoing upgrades to demonstrate a roadmap of features that can justify expansion within existing accounts or multi-site deployments.

Financial fit Address mid-market buyer segments by framing the technology as a cost-to-benefit investment through improved surgical accuracy, reduced re-operations, and potential reimbursement efficiency to align with revenue and efficiency drivers of smaller ophthalmic practices.